Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 9, 2023

Primary Completion Date

May 23, 2025

Study Completion Date

May 23, 2025

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Tandem Control IQ Hybrid Closed Loop Insulin Delivery System

The Tandem Control IQ hybrid closed loop insulin delivery system is made up of an externally worn Tandem insulin pump which communicates wirelessly to the Dexcom G6 CGM worn as a patch on the skin. The CGM measures glucose levels transmitting them into the computer within the pump. The computer then calculates how much insulin is required then dose delivery completes the cycle. The Control-IQ™ advanced technology adjusts insulin delivery to avoid glycaemic excursions, while still allowing the user to manually bolus at mealtimes.

Trial Locations (1)

EH4 2XU

Professor John McKnight, Edinburgh

All Listed Sponsors
collaborator

DexCom, Inc.

INDUSTRY

lead

NHS Lothian

OTHER_GOV

NCT05059860 - Dexcom Hybrid Closed Loop Insulin Pump Study in Type 1 Diabetes | Biotech Hunter | Biotech Hunter